US$ 24.75
ghk-cu injection clinical trial human The Effect of the Peptide GHK on Gene Expression Relevant to Nervous System Function and Cognitive Decline The potential of GHK as
Description
10.1016/j.ymeth.2007.06.009 102 MaroliG.SchnzerA.GntherS.Garcia-GonzalezC.RuppS.SchlierbachH.et al (2024)

By reducing the activity of macrophages and impeding the infiltration of inflammatory elements into the brain parenchyma, bevacizumab contributes to a neuroprotective milieu (Genovese and Impellizzeri 2022)

Both compounds remain in clinical development as of 2026
The peptide is currently being studied under research protocols and has not yet been approved by the FDA for general medical use

Inject solvent slowly down the inner wall of the vial
